Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Haardt
Martin Haardt, Plaue DE
| Patent application number | Description | Published |
|---|---|---|
| 20100054113 | Method for Selection of an Optimized Number of Subscribers in Mobile Radio Systems - This invention comprises a method of little complexity for selection of an optimized number of subscribers for transmission in wire-free message transmission systems having a plurality of antennas at the base station and having one or more antennas at the receivers, as well as space-division multiple access (SDMA) in conjunction with multiple access in the time domain or frequency domain. Subscribers with channels with little spatial correlation art selected for operation in the same time slot or frequency slot. In order to increase the throughput of the SDMA transmission method, with the relationship between the group size and the mean transmission power being taken into account. The invention interacts both with SDMA methods which do not allow any interference (Zero Forcing) and with methods with residual interference. It is based on a novel interpretation of the ZF principle with the aid of orthogonal projection matrices, which allow the channel quality to be estimated with much less computation complexity, based on use or the transmission method. The possible subscriber combinations are sorted efficiently with the aid or a tree-like search algorithm. The method makes use of perfect channel knowledge or alternatively averaged channel statistics. Quality of service requirements for the subscriber as well as fairness criteria can be taken into account. | 03-04-2010 |
Martin Haardt, Coldbrook CA
| Patent application number | Description | Published |
|---|---|---|
| 20090060900 | Methods for Screening Compounds That Modulate Lipid Metabolism - Drug screening assays useful in the discovery of pharmaceutically active compounds for use in the treatment of diseases involving abnormal lipid metabolism including diabetic neuropathy are taught. In particular, the control region of delta-5-desaturase gene is taught as a target for the drug screening methods, which serve to identify nucleotides, proteins, compounds and/or other pharmacological agents, which modulate the activity of desaturase enzymes or regulate the level of expression of the desaturase genes. Cell-based and cell lysate assays are taught for detecting components that interact with the desaturase enzymes and modify fatty acid profiles. In addition, cell-based and cell lysate assays are used to identify functional and regulatory elements controlling expression of the desaturase genes as well as to screen for components that modulate the transcriptional activity of the desaturase genes. Also taught is the gene for rat delta-5-desaturase. | 03-05-2009 |
Martin Haardt, Edmonton CA
| Patent application number | Description | Published |
|---|---|---|
| 20080220500 | Human Elongase Genes, Uses Thereof, and Compounds for Modulating Same - The present invention relates to elongase genes, their polypeptides and their control regions, and the use of such genes, polypeptides and control regions in determining compositions for use in the treatment of disease. The identified compositions regulate the expression of the elongase genes or modulate the activity of their protein products. The nucleotide and amino acid sequences are taught for ELG4, ELG6 and ELG7. The control sequences and function are taught for ELG1, ELG2, ELG3, ELG4, ELG5, ELG6 and ELG7. | 09-11-2008 |